| Management of sickle cell disease complications beyond acute chest syndrome UO Ogu, NU Badamosi, PE Camacho, AX Freire, P Adams-Graves Journal of Blood Medicine, 101-114, 2021 | 34 | 2021 |
| Successful management of blue rubber bleb nevus syndrome (BRBNS) with sirolimus UO Ogu, G Abusin, RF Abu-Arja, JM Staber Case reports in pediatrics 2018 (1), 7654278, 2018 | 24 | 2018 |
| Comorbidities in sickle cell disease: Adult providers needed! UO Ogu, HH Billett Indian Journal of Medical Research 147 (6), 527-529, 2018 | 22 | 2018 |
| L‐glutamine use in adults with sickle cell disease: Clinical trials where success meets reality UO Ogu, M Thomas, F Chan, L Vattappally, G Sebastian, A Crouch, S You, ... American Journal of Hematology 96 (1), E38-E40, 2021 | 19 | 2021 |
| Sickle cell disease in the new era: advances in drug treatment MT Lee, UO Ogu Transfusion and Apheresis Science 61 (5), 103555, 2022 | 13 | 2022 |
| Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease SS Tolu, A Crouch, J Choi, Q Gao, M Reyes-Gil, UO Ogu, G Vinces, ... Annals of Hematology 101 (3), 541-548, 2022 | 13 | 2022 |
| Reduced blood pressure of CFTR-F508del carriers correlates with diminished arterial reactivity rather than circulating blood volume in mice VA Peotta, P Bhandary, U Ogu, KA Volk, RD Roghair PLoS One 9 (5), e96756, 2014 | 13 | 2014 |
| Local anesthesia with general anesthesia for pediatric bone marrow procedures S Zarnegar-Lumley, KR Lange, MD Mathias, M Nakajima-Hatano, ... Pediatrics 144 (2), 2019 | 11 | 2019 |
| Hemoglobin F mitigation of sickle cell complications decreases with aging SS Tolu, M Reyes‐Gil, UO Ogu, M Thomas, EE Bouhassira, CP Minniti American Journal of Hematology 95 (5), E122-E125, 2020 | 8 | 2020 |
| Patient‐focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease C Bradford, H Miodownik, M Thomas, UO Ogu, CP Minniti American Journal of Hematology 97 (3), E93-E95, 2022 | 7 | 2022 |
| MicroRNA29B induces fetal hemoglobin via inhibition of the HBG repressor protein MYB in vitro and in humanized sickle cell mice Q Gu, CD Palani, A Smith, B Li, EK Amos-Abanyie, U Ogu, L Lu, BS Pace, ... Frontiers in Medicine 9, 1043686, 2022 | 4 | 2022 |
| Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease H Miodownik, SA Curtis, U Olivia Ogu, C Bradford, JL Starrels, ... British journal of haematology 196 (5), e41-e44, 2022 | 3 | 2022 |
| Barriers to the Use of Endari™ in an Urban Adult Sickle Cell Center UO Ogu, M Thomas, F Chan, G Sebastian, CP Minniti Blood 134, 2287, 2019 | 3 | 2019 |
| Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemia L Elsherif, P Kanthakumar, J Afolabi, AF Stratton, U Ogu, M Nelson, ... British Journal of Haematology 202 (3), 669-673, 2023 | 2 | 2023 |
| First Report of Compound Heterozygosity for Hb S (HBB: c.20A>T) and Hb Haringey (HBB: c.131A>G) UO Ogu, M Reyes Gil, SS Tolu, SA Acharya, CP Minniti Hemoglobin 45 (2), 136-139, 2021 | 2 | 2021 |
| High hemoglobin F in sickle cell disease: Waning protection with age SS Tolu, MR Gil, UO Ogu, J Choudhuri, R Fecher, G Sebastian, CP Minniti Blood 134, 3576, 2019 | 2 | 2019 |
| Clinical characteristics and health care utilization patterns of sickle cell disease patients using marijuana H Miodownik, C Bradford, JL Starrels, UO Ogu, M Thomas, ... Blood 132, 3669, 2018 | 2 | 2018 |
| Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia L Elsherif, Y Tang, KL Patillo, D Wichlan, UO Ogu, K Landes, P McCune, ... British Journal of Haematology 205 (5), 1963-1973, 2024 | 1 | 2024 |
| Hydroxyurea at escalated dose versus fixed low‐dose hydroxyurea in adults with sickle cell disease UO Ogu, A Mukhopadhyay, K Patel, MN Nelson, KLS Strahan, L Wu, ... European Journal of Haematology 112 (3), 466-474, 2024 | 1 | 2024 |
| miRNA29B induces fetal hemoglobin through targeting DNMT3 and MYB in vitro and in vivo in preclinical Townes sickle cell mice E Amos-Abanyie, C Palani, A Smith, Q Gu, U Ogu, D Johnson, ... Blood 140 (Supplement 1), 2496-2497, 2022 | 1 | 2022 |
